Medicago’s Canada-made COVID-19 vaccine faces WHO rejection due to tobacco industry ties | Globalnews.ca

Dr. Mariângela Simão, WHO’s assistant director-general for access to medicines and health products, spoke about the vaccine during a press briefing Wednesday.— so the process is put on hold because it’s well known that the WHO and UN have a very strict policy regarding engagement with tobacco and arms industries,” she said. “So the process is on hold.

The Quebec-based biopharmaceutical company’s vaccine marks the world’s first-ever plant-based jab for human use. The vaccine, called Covifenz, is comprised of two doses that must be administered 21 days apart, based on evidence from clinical trials. The company submitted its last phase of data, which included 30,000 volunteers, for regulatory review by

in December 2021. The latter approved Medicago’s vaccine for use in late February, for people aged between 18 and 64.

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Quebec's Medicago COVID-19 vaccine faces WHO rejection over company's tobacco ties | CBC NewsThe World Health Organization has paused the process for pre-qualification of Quebec City-based Medicago's new Covifenz shot due to its link to cigarette manufacturer Philip Morris International. WHO - virtual signalling Not part of the club. Unbelievable. the WHO is rejecting it? it must actually work.
Fonte: CBCNews - 🏆 2. / 99 Leggi di più »

WHO puts approval of Quebec's Medicago COVID-19 vaccine on hold due to tobacco industry ties: reportMedicago a small Canadian vaccine producer. Moderna physer 2 large billion dollar vaccine manufacturers. 1 in U.S. the other in Europe, neither can afford another manufacturer taking a piece of the pie. Especially when Maderna just set the stage for dose 4. This is daft. WHO needs to focus on medicine not politics.
Fonte: CTVNews - 🏆 1. / 99 Leggi di più »